Plerixafor stem cell mobilization in Japanese children: A post-marketing study.
Hiroaki GotoRie KanamoriSatoshi NishinaTakashi SetoPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2022)
The results provide an encouraging sign that plerixafor 0.24 mg/kg may be safe and effective in pediatric patients in routine clinical practice in Japan, but further research in larger studies is needed.